JP2015224251A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015224251A5 JP2015224251A5 JP2015108569A JP2015108569A JP2015224251A5 JP 2015224251 A5 JP2015224251 A5 JP 2015224251A5 JP 2015108569 A JP2015108569 A JP 2015108569A JP 2015108569 A JP2015108569 A JP 2015108569A JP 2015224251 A5 JP2015224251 A5 JP 2015224251A5
- Authority
- JP
- Japan
- Prior art keywords
- albumin solution
- albumin
- dissolved oxygen
- solution
- inert gas
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000009027 Albumins Human genes 0.000 claims 15
- 108010088751 Albumins Proteins 0.000 claims 15
- 238000000034 method Methods 0.000 claims 13
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 8
- 239000001301 oxygen Substances 0.000 claims 8
- 229910052760 oxygen Inorganic materials 0.000 claims 8
- 239000011261 inert gas Substances 0.000 claims 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 4
- 102000008100 Human Serum Albumin Human genes 0.000 claims 2
- 108091006905 Human Serum Albumin Proteins 0.000 claims 2
- 239000001307 helium Substances 0.000 claims 2
- 229910052734 helium Inorganic materials 0.000 claims 2
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 claims 2
- 239000000463 material Substances 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 229910052757 nitrogen Inorganic materials 0.000 claims 2
- 238000009928 pasteurization Methods 0.000 claims 2
- 230000005587 bubbling Effects 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000007789 gas Substances 0.000 claims 1
- 239000011521 glass Substances 0.000 claims 1
- 230000009261 transgenic effect Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES201430824A ES2524516B1 (es) | 2014-05-29 | 2014-05-29 | Procedimiento de preparación de albúmina humana con nivel de oxígeno disuelto reducido |
| ESP201430824 | 2014-05-29 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018086673A Division JP2018115210A (ja) | 2014-05-29 | 2018-04-27 | 溶存酸素レベルが低減されたヒトアルブミンの調製方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015224251A JP2015224251A (ja) | 2015-12-14 |
| JP2015224251A5 true JP2015224251A5 (enExample) | 2016-12-28 |
Family
ID=52003454
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015108569A Pending JP2015224251A (ja) | 2014-05-29 | 2015-05-28 | 溶存酸素レベルが低減されたヒトアルブミンの調製方法 |
| JP2018086673A Pending JP2018115210A (ja) | 2014-05-29 | 2018-04-27 | 溶存酸素レベルが低減されたヒトアルブミンの調製方法 |
| JP2020074749A Pending JP2020111614A (ja) | 2014-05-29 | 2020-04-20 | 溶存酸素レベルが低減されたヒトアルブミンの調製方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018086673A Pending JP2018115210A (ja) | 2014-05-29 | 2018-04-27 | 溶存酸素レベルが低減されたヒトアルブミンの調製方法 |
| JP2020074749A Pending JP2020111614A (ja) | 2014-05-29 | 2020-04-20 | 溶存酸素レベルが低減されたヒトアルブミンの調製方法 |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US10350274B2 (enExample) |
| EP (1) | EP2952203B9 (enExample) |
| JP (3) | JP2015224251A (enExample) |
| KR (1) | KR101960729B1 (enExample) |
| CN (1) | CN105315362B (enExample) |
| AR (1) | AR100618A1 (enExample) |
| AU (1) | AU2015202413B2 (enExample) |
| BR (1) | BR102015012091A8 (enExample) |
| CA (1) | CA2890642C (enExample) |
| CL (1) | CL2015001446A1 (enExample) |
| ES (2) | ES2524516B1 (enExample) |
| HU (1) | HUE031823T2 (enExample) |
| IL (1) | IL238898B (enExample) |
| MX (1) | MX362869B (enExample) |
| MY (1) | MY171771A (enExample) |
| NZ (1) | NZ708537A (enExample) |
| PL (1) | PL2952203T3 (enExample) |
| PT (1) | PT2952203T (enExample) |
| RU (1) | RU2657578C2 (enExample) |
| SG (1) | SG10201504137PA (enExample) |
| TW (1) | TWI607018B (enExample) |
| ZA (1) | ZA201503539B (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2524516B1 (es) * | 2014-05-29 | 2015-03-31 | Grifols Worldwide Operations Limited | Procedimiento de preparación de albúmina humana con nivel de oxígeno disuelto reducido |
| ES2900302T3 (es) | 2016-04-28 | 2022-03-16 | Alkahest Inc | Fracciones de plasma como terapia para el crecimiento y la progresión del tumor |
| HRP20211628T1 (hr) | 2016-08-18 | 2022-02-04 | Alkahest, Inc. | Frakcije krvne plazme kao tretman za kongitivne poremećaje povezane sa starenjem |
| BR112019022402A2 (pt) | 2017-04-26 | 2020-05-19 | Alkahest Inc | regime de dosagem para tratamento de comprometimentos cognitivo e motor com plasma sanguíneo e produtos de plasma sanguíneo |
| WO2020018343A1 (en) | 2018-07-20 | 2020-01-23 | Alkahest, Inc. | Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products |
| MX2021004755A (es) | 2018-10-26 | 2021-06-08 | Alkahest Inc | Uso de plasma y fracciones de plasma para mejorar el dolor, la cicatrizacion de heridas y la recuperacion posoperatoria. |
| CN109627322A (zh) * | 2019-01-07 | 2019-04-16 | 中国科学院过程工程研究所 | 一种从Cohn组分Ⅴ上清中分离纯化人血清白蛋白的方法 |
| CN114667151B (zh) | 2019-11-04 | 2025-05-23 | 万能溶剂有限公司 | 用于肌肉再生的血浆级分 |
| WO2021102032A1 (en) | 2019-11-20 | 2021-05-27 | Alkahest, Inc. | Blood plasma fractions for use in liver regeneration |
| WO2024200553A1 (en) | 2023-03-29 | 2024-10-03 | Grifols Worldwide Operations Limited | COMPOSITIONS AND METHODS OF PREPARATION OF BLOOD PLASMA PRODUCTS WITH REDUCED LEVELS OF FceRIß AUTOANTIBODIES |
| CN118166053B (zh) * | 2024-03-15 | 2025-02-07 | 通化安睿特生物制药股份有限公司 | 一种制备低o-糖基化水平的重组人白蛋白的方法 |
| WO2025230830A1 (en) | 2024-04-29 | 2025-11-06 | Alkahest, Inc. | Compositions of blood plasma fractions and their use in treatment of spinal muscular atrophy (sma) |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4094965A (en) * | 1977-04-01 | 1978-06-13 | New England Nuclear Corporation | Diagnostic agents containing albumin and method for making same |
| SE9301581D0 (sv) * | 1993-05-07 | 1993-05-07 | Kabi Pharmacia Ab | Protein formulation |
| JPH07126182A (ja) * | 1993-10-27 | 1995-05-16 | Green Cross Corp:The | 組換えヒト血清アルブミン製剤の滅菌方法 |
| SE9402119D0 (sv) * | 1994-06-16 | 1994-06-16 | Pharmacia Ab | Solution |
| US5766582A (en) * | 1994-10-11 | 1998-06-16 | Schering Corporation | Stable, aqueous alfa interferon solution formulations |
| JP4254117B2 (ja) * | 2001-03-27 | 2009-04-15 | ニプロ株式会社 | アルブミン溶液収容プラスチック容器 |
| DE60234142D1 (de) * | 2001-03-27 | 2009-12-10 | Nipro Corp | Albuminlösung enthaltender Kunststoffbehälter |
| WO2003002139A1 (fr) * | 2001-06-29 | 2003-01-09 | Asahi Kasei Kabushiki Kaisha | Procede permettant d'ameliorer la stabilite de la preparation de proteines |
| US7252799B2 (en) * | 2001-08-31 | 2007-08-07 | Clearant, Inc. | Methods for sterilizing preparations containing albumin |
| ATE342904T1 (de) * | 2003-08-28 | 2006-11-15 | Nipro Corp | Künstlicher sauerstoffträger und herstellungsverfahren dafür |
| JP5364382B2 (ja) * | 2006-02-07 | 2013-12-11 | シャイアー ヒューマン ジェネティック セラピーズ インコーポレイテッド | 遊離チオール部分を有するタンパク質の安定化された組成物 |
| ES2294976B1 (es) * | 2007-11-12 | 2008-12-16 | Grifols, S.A. | "procedimiento de obtencion de albumina humana de alta eficacia para su uso en terapia de detoxificacion". |
| JP5990880B2 (ja) * | 2011-08-31 | 2016-09-14 | 東レ株式会社 | 有用タンパク質組成物およびその製造方法 |
| CN102816230B (zh) * | 2012-08-27 | 2014-02-12 | 同路生物制药股份有限公司 | 人血白蛋白的制备方法 |
| ES2524516B1 (es) * | 2014-05-29 | 2015-03-31 | Grifols Worldwide Operations Limited | Procedimiento de preparación de albúmina humana con nivel de oxígeno disuelto reducido |
-
2014
- 2014-05-29 ES ES201430824A patent/ES2524516B1/es not_active Expired - Fee Related
-
2015
- 2015-04-01 HU HUE15382164A patent/HUE031823T2/en unknown
- 2015-04-01 PL PL15382164T patent/PL2952203T3/pl unknown
- 2015-04-01 PT PT153821640T patent/PT2952203T/pt unknown
- 2015-04-01 ES ES15382164.0T patent/ES2601137T3/es active Active
- 2015-04-01 EP EP15382164.0A patent/EP2952203B9/en active Active
- 2015-05-01 CA CA2890642A patent/CA2890642C/en active Active
- 2015-05-06 AU AU2015202413A patent/AU2015202413B2/en active Active
- 2015-05-15 MY MYPI2015701570A patent/MY171771A/en unknown
- 2015-05-18 RU RU2015118453A patent/RU2657578C2/ru active
- 2015-05-19 IL IL238898A patent/IL238898B/en active IP Right Grant
- 2015-05-20 ZA ZA2015/03539A patent/ZA201503539B/en unknown
- 2015-05-21 MX MX2015006407A patent/MX362869B/es active IP Right Grant
- 2015-05-22 CN CN201510264800.9A patent/CN105315362B/zh active Active
- 2015-05-26 SG SG10201504137PA patent/SG10201504137PA/en unknown
- 2015-05-26 TW TW104116876A patent/TWI607018B/zh not_active IP Right Cessation
- 2015-05-26 BR BR102015012091A patent/BR102015012091A8/pt not_active IP Right Cessation
- 2015-05-27 NZ NZ708537A patent/NZ708537A/en not_active IP Right Cessation
- 2015-05-27 AR ARP150101653A patent/AR100618A1/es active IP Right Grant
- 2015-05-28 JP JP2015108569A patent/JP2015224251A/ja active Pending
- 2015-05-28 CL CL2015001446A patent/CL2015001446A1/es unknown
- 2015-05-28 KR KR1020150074568A patent/KR101960729B1/ko active Active
- 2015-05-28 US US14/724,649 patent/US10350274B2/en active Active
-
2018
- 2018-04-27 JP JP2018086673A patent/JP2018115210A/ja active Pending
-
2020
- 2020-04-20 JP JP2020074749A patent/JP2020111614A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015224251A5 (enExample) | ||
| RU2015118453A (ru) | Способ получения человеческого альбумина с пониженным уровнем растворенного кислорода | |
| FI3237001T3 (fi) | Il-17-vasta-aineiden farmaseuttisia tuotteita ja stabiileja nestemäisiä koostumuksia | |
| MX366787B (es) | Derivados de sulfamoiltiofenamida y su uso como medicamentos para tratar la hepatitis b. | |
| ES2530841T3 (es) | Generación de plasma de CO para envasado en atmósfera modificada | |
| WO2014064410A3 (en) | Pharmaceutical composition comprising tiotropium and a hydrofluoroalkane | |
| PH12019500513A1 (en) | Mast cell stabilizers for treatment of hypercytokinemia and viral infection | |
| EP4548975A3 (en) | Nitric oxide inhalation therapy for infants with bronchiolitis | |
| MX363408B (es) | Composicion que contiene peroxido y acido peracetico y proceso para matar esporas. | |
| MX2016008662A (es) | Composicion farmaceutica que no contiene antioxidantes y metodo de preparacion de la misma. | |
| MX2016015804A (es) | Composiciones antimicrobianas que utilizan plata y oxigeno, proceso para elaborarlas y metodo para utilizarlas. | |
| IN2013MU03559A (enExample) | ||
| SG11201901617PA (en) | Azole compound ophthalmic preparation | |
| PH12015501898A1 (en) | Methods of handling papaya | |
| GEP20207107B (en) | Selected amide of γ-hydroxybutyric acid and uses thereof in the treatment of alcohol misuse | |
| JP2016154499A5 (enExample) | ||
| NZ722725A (en) | Flavour stable beverages | |
| PH12022551587A1 (en) | Composition containing sesamin and pqq | |
| JP2016086719A5 (enExample) | ||
| WO2016130786A3 (en) | Flaviviridae proteins and virions and methods of use thereof | |
| RU2016107835A (ru) | Способ хранения пищевого продукта | |
| NZ706264A (en) | Methods of handling persimmons | |
| EA201500694A1 (ru) | Монолитная лекарственная форма для модифицированного высвобождения комбинации активных ингредиентов | |
| PH12016501808A1 (en) | Chemical compounds | |
| MX2016007866A (es) | Composiciones de gases de soldadura y metodos de utilizacion. |